Fulgent Genetics, Inc. (FLGT) Enters Collaboration with Helio Health for Early Cancer Detection Tests

Go back to Fulgent Genetics, Inc. (FLGT) Enters Collaboration with Helio Health for Early Cancer Detection Tests

Fulgent Genetics, Inc. (FLGT) Misses Q2 EPS by 26c

August 9, 2021 4:12 PM EDT

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q2 EPS of $2.55, $0.26 worse than the analyst estimate of $2.81. Revenue for the quarter came in at $153.6 million versus the consensus estimate of $197.34 million.

GUIDANCE:

Fulgent Genetics, Inc. sees FY2021 EPS of $12.50, versus the consensus of... More